Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Safe and effective treatment of erectile dysfunction with sildenafil

Sep. 6, 1996

Joint venture to develop treatment for male impotence

Sep. 6, 1996

Bio-Technology General to seek approval for sublingual testosterone

Sep. 6, 1996

AGE-specific monoclonal antibody from Alteon

Sep. 6, 1996

Novo Nordisk licenses Scios' insulinotropin

Sep. 6, 1996

Location of gene linked to type 2 diabetes discovered

Sep. 6, 1996

Clinical results for Cortecs' oral insulin formulation

Sep. 6, 1996

Terumo pursues treatments for diabetes and complications

Sep. 6, 1996

Retinoid compound from Sparta enters U.S. clinical trials

Sep. 6, 1996

A new CETP inhibitor from Schering-Plough

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...